Join to view full profile
3614 Washington PkwyIdaho Falls, ID 83404
Phone+1 208-535-8400
Fax+1 208-535-8409
Dr. Buitrago is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Yale-New Haven Medical CenterFellowship, Infectious Disease, 1995 - 1998
Icahn School of Medicine at Mount Sinai/NYC Health and Hospitals (Queens)Residency, Internal Medicine, 1993 - 1995
Zucker School of Medicine at Hofstra/NorthwellResidency, Internal Medicine, 1991 - 1993
Colegio Mayor de Nuestra Señora del RosarioClass of 1988
Certifications & Licensure
ID State Medical License 2002 - 2030
CT State Medical License 1996 - 2003
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Infectious Disease
National Board of Physicians and Surgeons Infectious Disease- National Board of Physicians and Surgeons Internal Medicine
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification eClinicalWorks, eClinicalWorks, LLC, 2012, 2014-2016
- CMS Meaningful Use Stage 2 Certification eClinicalWorks, eClinicalWorks, LLC, 2012, 2014-2016
- CMS Meaningful Use Stage 1 Certification eClinicalWorks EHR, eClinicalWorks LLC, 2012-2013
Clinical Trials
Publications & Presentations
PubMed
- 2 citationsTherapy for HIV-associated cryptococcal meningitis: a case report demonstrating a new treatment approach emphasizing updated treatment guidelines.David M Hachey, Brian R Wood, Martha Buitrago, Anushka Burde
Drugs & Therapy Perspectives. 2023-06-12 - 47 citationsCadazolid for the treatment of Clostridium difficile infection: results of two double-blind, placebo-controlled, non-inferiority, randomised phase 3 trials.Dale N. Gerding, Oliver A. Cornely, Simon Grill, Hilke Kracker, Anne Claire Marrast
The Lancet. Infectious Diseases. 2019-03-01 - 65 citationsMulticenter, Double-Blind, Randomized, Phase 2 Study Evaluating the Novel Antibiotic Cadazolid in Patients with Clostridium difficile InfectionThomas J. Louie, Carl Erik Nord, George H. Talbot, Mark H. Wilcox, Dale N. Gerding
Antimicrobial Agents and Chemotherapy. 2015-10-01
Press Mentions
Life After the COVID Vaccine: What's Safe, and What Isn't? Local Doctors Weigh InApril 26th, 2021
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
